Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas. [electronic resource]
Producer: 20100310Description: 71-8 p. digitalISSN:- 1546-1696
- Adenocarcinoma -- metabolism
- Animals
- Chimera -- metabolism
- Disease Models, Animal
- Embryonic Stem Cells -- drug effects
- ErbB Receptors -- metabolism
- Lung Neoplasms -- metabolism
- Mice
- Mice, Transgenic
- Mutation -- genetics
- Phenotype
- Piperazines -- pharmacology
- Proto-Oncogene Proteins p21(ras) -- metabolism
- Quinazolines -- pharmacology
- Respiratory Insufficiency -- metabolism
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.